Vortmeyer Alexander O, Alomari Ahmed K
Yale School of Medicine, Department of Pathology, Division of Neuropathology, Connecticut, USA.
J Kidney Cancer VHL. 2015 Jun 11;2(3):114-129. doi: 10.15586/jkcvhl.2015.35. eCollection 2015.
Von Hippel-Lindau (VHL) disease is a tumor syndrome that frequently involves the central nervous system (CNS). It is caused by germline mutation of the VHL gene. Subsequent VHL inactivation in selected cells is followed by numerous well-characterized molecular consequences, in particular, activation and stabilization of hypoxia-inducible factors HIF1 and HIF2. The link between VHL gene inactivation and tumorigenesis remains poorly understood. Hemangioblastomas are the most common manifestation in the CNS; however, CNS invasion by VHL disease-associated endolymphatic sac tumors or metastatic renal cancer also occur, and their differentiation from primary hemangioblastoma may be challenging. Finally, in this review, we present recent morphologic insights on the developmental concept of VHL tumorigenesis which is best explained by pathologic persistence of temporary embryonic progenitor cells.
冯·希佩尔-林道(VHL)病是一种常累及中枢神经系统(CNS)的肿瘤综合征。它由VHL基因的种系突变引起。在特定细胞中随后发生的VHL失活会伴随许多已充分表征的分子后果,特别是缺氧诱导因子HIF1和HIF2的激活和稳定。VHL基因失活与肿瘤发生之间的联系仍知之甚少。成血管细胞瘤是CNS中最常见的表现;然而,VHL病相关的内淋巴囊肿瘤或转移性肾癌也可侵犯CNS,并且将它们与原发性成血管细胞瘤区分开来可能具有挑战性。最后,在本综述中,我们展示了关于VHL肿瘤发生发展概念的最新形态学见解,这可以通过临时胚胎祖细胞的病理持续性得到最好的解释。